Effect of Dietary Monosodium Glutamate on HFCS-Induced Hepatic Steatosis: Expression Profiles in the Liver and Visceral Fat

Obesity

Volumn 18, Issue 6, 2010, Pages 1122-1134

  Collison, Kate S ^a   Maqbool, Zakia M ^a   Inglis, Angela L ^a   Makhoul, Nadine J ^a   Saleh, Soad M ^a   Bakheet, Razan H ^a   Al Johi, Mohammed A ^a   Al Rabiah, Rana K ^a   Zaidi, Marya Z ^a   Al Mohanna, Futwan A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CORN SYRUP; FATTY ACID; GLUTAMATE SODIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; FRUCTOSE; HORMONE; LIPID;

ADIPOCYTE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID SYNTHESIS; C57BL 6 MOUSE; CARBOHYDRATE METABOLISM; CELL DIFFERENTIATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DOWN REGULATION; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID METABOLISM; LIVER; LIVER LEVEL; LONG TERM EXPOSURE; MALE; MATERNAL NUTRITION; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PPARGC1A GENE; PROGENY; RESPIRATORY CHAIN; SREBF2 GENE; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DIET; DNA MICROARRAY; DRUG EFFECT; EVALUATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; MAIZE; METABOLISM; PREGNANCY; CHEMICALLY INDUCED; DRUG EFFECTS; EVALUATION STUDY;

ANIMALS; DIET; DYSLIPIDEMIAS; FATTY LIVER; FEMALE; FRUCTOSE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HORMONES; INTRA-ABDOMINAL FAT; LIPID METABOLISM; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; SODIUM GLUTAMATE; ZEA MAYS;

ANIMALIA; MUS; ZEA MAYS;

EID: 77952955398     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.502     Document Type: Article

References (45)

1. Preiss D, Sattar N,. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci 2008; 115: 141-150.
2. Luyckx FH, Lefebvre PJ, Scheen AJ,. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000; 26: 98-106.
3. Herruzo JA Solís, Ruiz I García, Carreras M Pérez, Yagüe MT Muñoz,. Non-alcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction. Rev Esp Enferm Dig 2006; 98: 844-874.
4. Basciano H, Federico L, Adeli K,. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2005; 2: 5.
5. Cave M, Deaciuc I, Mendez C, et al., Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem 2007; 18: 184-195.
6. Bray GA, Nielsen SJ, Popkin BM,. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79: 537-543.
7. US Department of Agriculture, Economic Research Service, 2005 Figures. < http:www.ers.usda.govPublicationsEIB33EIB33.pdf >.
8. Collison KS, Makhoul NJ, Inglis A, et al., Dietary trans-fat combined with monosodium glutamate induces dyslipidemia and impairs spatial memory. Physiol Behav 2009; e-pub ahead of print.
9. Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA,. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 2008; 295: G987-G995.
10. Hirata AE, Andrade IS, Vaskevicius P, Dolnikoff MS,. Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res 1997; 30: 671-674.
11. Larsen PJ, Mikkelsen JD, Jessop D, Lightman SL, Chowdrey HS,. Neonatal monosodium glutamate treatment alters both the activity and the sensitivity of the rat hypothalamo-pituitary-adrenocortical axis. J Endocrinol 1994; 141: 497-503.
12. Matysková R, Maletínská L, Maixnerová J, et al., Comparison of the obesity phenotypes related to monosodium glutamate effect on arcuate nucleus and/or the high fat diet feeding in C57BL/6 and NMRI mice. Physiol Res 2008; 57: 727-734.
13. Dolnikoff M, Martín-Hidalgo A, Machado UF, Lima FB, Herrera E,. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats. Int J Obes Relat Metab Disord 2001; 25: 426-433.
14. FAO/WHO. Toxicological evaluation of certain food additives with a review of general principles and of specifications. 17th Report of the Joint FAO/WHO Expert Committee on Food Additives. FAO Nutrition Meetings Report Series no. 53, WHO Technical Report Series no. 539, 1974. < http:www.mhlw.go.jpshingi200807dls0730-12e-0004.pdf >
15. Beyreuther K, Biesalski HK, Fernstrom JD, et al., Consensus meeting: monosodium glutamate-an update. Eur J Clin Nutr 2007; 61: 304-313.
16. Nakanishi Y, Tsuneyama K, Fujimoto M, et al., Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. J Autoimmun 2008; 30: 42-50.
17. Morash BA, Willkinson D, Ur E, Wilkinson M,. Resistin expression and regulation in mouse pituitary. FEBS Lett 2002; 526: 26-30.
18. Adkins JS, Lynch JF, Lewis LM,. Monosodium glutamate-induced hyperglycemia in weanling rats. Fedn Proc 1971; 30: 460 Abstr.
19. Matthews DR, Hosker JP, Rudenski AS, et al., Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Collison KS, Maqbool Z, Saleh SM, et al., Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. J Lipid Res 2009; 50: 1521-1537.
21. Irizarry RA, Hobbs B, Collin F, et al., Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
22. Shiman HO,. Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. Vitam Horm 2002; 65: 167-194.
23. Fabbrini E, Mohammed BS, Magkos F, et al., Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 2008; 134: 424-431.
24. Barzilai N, She L, Liu BQ, et al., Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999; 48: 94-98.
25. Park SH, Kim BI, Yun JW, et al., Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol 2004; 19: 694-698.
26. Nakamuta M, Kohjima M, Higuchi N, et al., The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease. Int J Mol Med 2008; 22: 663-667.
27. Tamura S, Shimomura I,. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1139-1142.
28. Zhang L, Perdomo G, Kim DH, et al., Proteomic analysis of fructose-induced fatty liver in hamsters. Metab Clin Exp 2008; 57: 1115-1124.
29. Kelley GL, Allan G, Azhar S,. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 2004; 145: 548-555.
30. Guthrie JF, Morton JF,. Food sources of added sweeteners in the diets of Americans. J Am Diet Assoc 2000; 100: 43-51, quiz 49.
31. Payne VA, Arden C, Lange AJ, Agius L,. Contributions of glucokinase and phosphofructokinase-2/fructose bisphosphatase-2 to the elevated glycolysis in hepatocytes from Zucker fa/fa rats. Am J Physiol Regul Integr Comp Physiol 2007; 293: R618-R625.
32. Mayes PA,. Intermediary metabolism of fructose. Am J Clin Nutr 1993; 58: 754S-765S.
33. Negishi M, Aida K, Yoshioka H,. Sexually dimorphic expression of P-450 genes. In:, Omura T, Tshimura Y, Fujii-Kuriyama Y, (eds). Cytochrome P450. Kodansha: Tokyo, 1993, pp. 230-241.
34. Zangar RC, Novak RF,. Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes. Arch Biochem Biophys 1997; 337: 217-224.
35. Cherkaoui-Malki M, Meyer K, Cao WQ, et al., Identification of novel peroxisome proliferator-activated receptor α (PPARα) target genes in mouse liver using cDNA microarray analysis. Gene Expr 2001; 9: 291-304.
36. Bradbury MW,. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol 2006; 290: G194-G198.
37. Tiemann M, Han Z, Soccio R, et al., Cholesterol feeding of mice expressing cholesterol 7α-hydroxylase increases bile acid pool size despite decreased enzyme activity. Proc Natl Acad Sci USA 2004; 101: 1846-1851.
38. Masson D, Qatanani M, Sberna AL, et al., Activation of the constitutive androstane receptor decreases HDL in wild-type and human apoA-I transgenic mice. J Lipid Res 2008; 49: 1682-1691.
39. Labbe G, Pessayre D, Fromenty B,. Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies. Fundam Clin Pharmacol 2008; 22: 335-353.
40. Natarajan SK, Eapen CE, Pullimood AB, Balasubramanian KA,. Oxidative stress in experimental liver microvesicular steatosis: role of mitochondria and peroxisomes. J Gastroenterol Hepatol 2006; 21: 1240-1249.
41. Cortõn M, Botella-Carretero JI, Lõpez JA, et al., Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum Reprod 2008; 23: 651-661.
42. Darimont C, Avanti O, Blancher F, et al., Contribution of mesothelial cells in the expression of inflammatory-related factors in omental adipose tissue of obese subjects. Int J Obes (Lond) 2008; 32: 112-120.
43. Do Carmo S, Fournier D, Mounier C, Rassart E,. Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism. Am J Physiol Endocrinol Metab 2009; 296: E802-E811.
44. Mootha VK, Lindgren CM, Eriksson KF, et al., PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.
45. He K, Zhao L, Daviglus ML, et al.,; INTERMAP Cooperative Research Group. Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP Study. Obesity (Silver Spring) 2008; 16: 1875-1880.